Vimarsana
Biggest News Aggregation in the World

Add On Code News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Add On Code. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Add On Code Today - Breaking & Trending Today

Congressional Health Policy Outlook for 2023 | Akin Gump Strauss Hauer & Feld LLP - Vimarsana News

Congressional Health Policy Outlook for 2023 | Akin Gump Strauss Hauer & Feld LLP

The House and Senate convened this week to kick off the 118th Congress. Republicans control the House after four years of a Democratic majority. House Republicans have a very slim...

H&K Health Dose: January 5, 2023 - Healthcare - Vimarsana News

H&K Health Dose: January 5, 2023 - Healthcare

Welcome to the 118th Congress. This session of Congress is convening on the heels of the enactment of the Consolidated Appropriations Act (CAA), 2023, which was signed into law on Dec. 29, 2022.

Source: mondaq.com
Congressional Health Policy Outlook for 2023 - Vimarsana News

Congressional Health Policy Outlook for 2023

The House and Senate convened this week to kick off the 118th Congress. Republicans control the House after four years of a Democratic majority…

Year-End Appropriations Bill Includes Myriad Medicare Policy Changes | Manatt, Phelps & Phillips, LLP - Vimarsana News

Year-End Appropriations Bill Includes Myriad Medicare Policy Changes | Manatt, Phelps & Phillips, LLP

The Big Picture Until late December, few if any Medicare policy changes were anticipated as part of a year-end healthcare package, barring extensions of funding for programs that otherwise would have expired. But after several days of closed-door negotiations, congressional leaders unveiled—and very shortly thereafter Congress passed—a legislative package containing an amalgam of Medicare policy changes. The Consolidated Appropriations Act, 2021 (the Act) includes significant payment adjustments, rural health improvements, transparency requirements for certain manufacturers of drugs cover...